Font Size: a A A
Keyword [HER2]
Result: 1 - 20 | Page: 1 of 10
1. Investigation Of The Synergersitic Cytotoxicity And Mechanism Of Small Molecular Tyrosine Kinase Inhibitors AG825 Or AG1478 Combine With Cisplatin On NSCLC Cell Lines
2. Construction, Expression, And Activity Of A Genetic Engineered Anti-HER2/neu×Anti-CD16 Bispecific Antibody
3. Experimental Studies On Highly Specific HER2/neu Chiral Peptide Vaccine
4. Structure Of Recombinant Adenovirus Encoding Her-2/neu Gene Of Extracellular And Transmembrane Domains Protein And Their Eliciting Immunological Response
5. The Effect And The Mechanism Of HER2/neu Overexpression On The Amount Of P53 Protein And Cell Proliferation And Apoptosis In Breast Cancer Cells
6. Study On The Expression Of HER2-targeted Chimeric T-cell Receptor Gene In Lymphohemopoietic Cells And Its Anti-tumor Effects
7. BCG Heat Shock Protein65-HER2 Multiple-Epitopes Fusion Protein
8. Anti-tumor Immunotherapy With Anti-HER2 Antibody/Flt3L Bispecific Fusion Protein
9. Construction And Functional Study Of Heat Shock Protein 65-HER2 Multi-Epitopes Fusion Protein
10. Experimental Study On Inhibitory Effect Of RNAi On The Expression Of Her2/neu In Breast Cancer
11. Study On Prognostic Factors Of Lymph Node-Negative Breast Cancer
12. Inhibition Of NSCLC Cell Proliferation And Tumor Growth By Vector Based-small Interfering RNA Targeting HER2/neu
13. Chemosensitivity To Lidamycin In Cancer Cells Overexpressing HER2 And Mdr1
14. Study Of HER2 Gene Silencing By RNA Interference
15. Inhibited Proliferation Of Human Breast Carcinoma Cells By RNA Interference-based Knockdown Of ErbB2/HER2
16. Construction Of Energized Fusion Protein Consisting Of Anti-HER2 ScFv And Lidamycin And Its Antitumor Activity
17. HER2 Overexpression And Its Mediated Signaling Pathway Upregulate The Expression Of Matrix Metalloproteinase-7
18. Studies On Production Of Recombinant HER2/neu ICD And Its Anti-tumor Effects
19. Clonal Origins And PIK3CA Mutations Of Benign And Malignant Proliferative Lesions Of The Breast
20. The Construction Of A Bispecific Energized Fusion Protein Consisting Of Epidermal Growth Factor Receptor/EGFR And HER2 Peptide Ligands And Lidamycin And Its Antitumor Activity
  <<First  <Prev  Next>  Last>>  Jump to